Bioventus
Derek Hurdle has a diverse work experience in the pharmaceutical and medical industry. Derek started their career as a Pharmaceutical Representative at Merck from 2006 to 2009. Derek then joined Takeda as a Pharmaceutical Representative from 2009 to 2011. Derek's significant work experience began at Bioventus in 2011, where they held various roles and demonstrated impressive achievements. Derek served as a Clinical Therapies Sales Specialist from 2011 to 2015 and progressed to become a Director of Sales from 2015 to 2017. Derek's role expanded to include sales education and training as the Director of Sales Education & Training from 2017 to 2018. Derek then transitioned to a more strategic role as the Senior Director of Marketing for North America from 2017 to 2022. In this role, they were responsible for the total portfolio, led a team of 16 marketers, and spearheaded initiatives that resulted in significant revenue growth. Derek then took on the role of Vice President of Sales for the Pain Treatments Division from 2022 to 2023, where they played a crucial role in driving sales growth and overseeing marketing strategies. Derek's most recent position at Bioventus is as the Vice President of Sales and Marketing for the Pain Treatments Division, which they started in 2023. Overall, Derek Hurdle has demonstrated a strong track record of success and leadership in the pharmaceutical and medical industry.
Derek Hurdle obtained their B.S.B.A degree in Finance from East Carolina University in 2003, and later pursued a Master of Business Administration (MBA) in Finance from the same institution, completing it in 2006.
Bioventus
4 followers
Bioventus® is a global leader in orthobiologics and its mission is to make a difference by helping patients resume and enjoy active lives. Bioventus accomplishes this with its orthobiologic solutions for musculoskeletal healing and regeneration that engage and enhance the body’s healing process. The company has products for bone healing, bone graft and knee osteoarthritis. Established in 2012, Bioventus is privately held and headquartered in Durham, NC. The company has more than 700 employees worldwide and its international headquarters is in Hoofddorp, The Netherlands. Bioventus also has offices in Memphis, TN and Toronto, Ontario, Canada. Bioventus works with patients, payers and health care providers throughout the world, and generates $300 million dollars in yearly revenue.